Schedule 13G ownership disclosure

EDESA BIOTECH INC

Common Stock, without par value · CUSIP: 27966L306

Event date: 2024-12-31

Filing-level shares
232,161.00
Percent of class
6.7%
  • Thomas A. Satterfield, Jr.

    Shares: 232,161.00 · Class: 6.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-011845
Form type
SCHEDULE 13G/A
Filer
Edesa Biotech, Inc.
CIK
CIK 1540159
Filed
Feb 12, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub